Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis

被引：12
|
作者：
Sui, Jing [1 ,2 ]
Qiao, Wenliang [3 ]
Xiang, Xinrong [1 ,2 ]
Luo, Youfu [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China
[3] Sichuan Univ, Lung Canc Ctr, Lab Lung Canc, Western China Hosp, Chengdu, Peoples R China
来源：
PHARMACOLOGICAL RESEARCH | 2022年 / 179卷
基金：
中国国家自然科学基金;
关键词：
Mycobacterium tuberculosis; Epigenetics; DNA methylation; Histone modification; MicroRNA; METALLOPROTEINASE-1; AND-3; EXPRESSION; RIBOSOMAL-RNA METHYLTRANSFERASE; NF-KAPPA-B; DNA METHYLATION; IMMUNE-RESPONSES; CPG DNA; MATRIX METALLOPROTEINASES; DIRECTED THERAPY; INNATE IMMUNITY; VITAMIN-D;
D O I：
10.1016/j.phrs.2022.106195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Tuberculosis infection caused by the contagious pathogen Mycobacterium tuberculosis (MTB) is one of the ancient diseases in the world. The problem of drug resistance is a difficulty in tuberculosis treatment. MTB engendered epigenetic changes play vital parts in escaping the host immune response and bring about the persistence as well as bacterial expansion. This article describes the epigenetic changes that occur in the pathogen MTB and its host during infection, including DNA methylation, histone modification and microRNA, and summarizes their research progress in drug discovery and tuberculosis diagnosis, providing new ideas and strategies to combat against drug-resistant tuberculosis.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Comparative analyses of the proteins from Mycobacterium tuberculosis and human genomes: Identification of potential tuberculosis drug targets
    Sridhar, Settu
    Dash, Pallabini
    Guruprasad, Kunchur
    GENE, 2016, 579 (01) : 69 - 74
  • [32] CRISPR/Cas9 screens identify novel Mycobacterium tuberculosis host cell death restriction factors as potential drug targets for treatment of Tuberculosis
    Doerflinger, M.
    Stutz, M.
    Milla, L.
    Herold, M. J.
    Pellegrini, M.
    CELL DEATH DISCOVERY, 2019, 5
  • [33] An In silico Approach to Identify Potential Inhibitors against Multiple Drug Targets of Mycobacterium tuberculosis
    Kumar, Satish
    Sahu, Parameswar
    Jena, Lingaraja
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2019, 8 (03) : 252 - 261
  • [34] Proteins with Complex Architecture as Potential Targets for Drug Design: A Case Study of Mycobacterium tuberculosis
    Meszaros, Balint
    Toth, Judit
    Vertessy, Beata G.
    Dosztanyi, Zsuzsanna
    Simon, Istvan
    PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (07)
  • [35] Potential of Mycobacterium tuberculosis Type II NADH-Dehydrogenase in Antitubercular Drug Discovery
    Saha, Pallavi
    Kumar, Mohit
    Sharma, Deepak K.
    ACS INFECTIOUS DISEASES, 2025,
  • [36] Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
    Dambrova, Maija
    Makrecka-Kuka, Marina
    Kuka, Janis
    Vilskersts, Reinis
    Nordberg, Didi
    Attwood, Misty M.
    Smesny, Stefan
    Sen, Zumrut Duygu
    Guo, An Chi
    Oler, Eponine
    Tian, Siyang
    Zheng, Jiamin
    Wishart, David S.
    Liepinsh, Edgars
    Schioth, Helgi B.
    PHARMACOLOGICAL REVIEWS, 2022, 74 (03) : 506 - 551
  • [37] Pangenome Analysis of Mycobacterium tuberculosis Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
    Dar, Hamza Arshad
    Zaheer, Tahreem
    Ullah, Nimat
    Bakhtiar, Syeda Marriam
    Zhang, Tianyu
    Yasir, Muhammad
    Azhar, Esam I.
    Ali, Amjad
    ANTIBIOTICS-BASEL, 2020, 9 (11): : 1 - 14
  • [38] Epidermal Differentiation Complex: A Review on Its Epigenetic Regulation and Potential Drug Targets
    Abhishek, Sinha
    Krishnan, Suresh Palamadai
    CELL JOURNAL, 2016, 18 (01) : 1 - 6
  • [39] Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobacterium tuberculosis
    Gadre, DV
    Talwar, V
    Gupta, HC
    Murthy, PS
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (03) : 129 - 131
  • [40] Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy
    Torfs, Eveline
    Piller, Tatiana
    Cos, Paul
    Cappoen, Davie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)
12345